NORTHSTAR ASSET MANAGEMENT Co Has $506,000 Stock Position in SPDR S&P Biotech ETF $XBI

NORTHSTAR ASSET MANAGEMENT Co reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 6,100 shares of the exchange traded fund’s stock after selling 225 shares during the period. NORTHSTAR ASSET MANAGEMENT Co’s holdings in SPDR S&P Biotech ETF were worth $506,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Investment Partners Asset Management Inc. boosted its position in SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after purchasing an additional 125 shares during the period. Compass Ion Advisors LLC boosted its position in SPDR S&P Biotech ETF by 3.9% during the second quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock worth $309,000 after purchasing an additional 140 shares during the period. McAdam LLC boosted its position in SPDR S&P Biotech ETF by 5.1% during the second quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after purchasing an additional 159 shares during the period. First Heartland Consultants Inc. boosted its position in SPDR S&P Biotech ETF by 2.7% during the first quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock worth $514,000 after purchasing an additional 168 shares during the period. Finally, Calton & Associates Inc. boosted its position in SPDR S&P Biotech ETF by 3.2% during the first quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock worth $459,000 after purchasing an additional 175 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $108.39 on Friday. The company has a fifty day moving average price of $98.08 and a two-hundred day moving average price of $87.75. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $110.96. The stock has a market cap of $6.65 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.